93 related articles for article (PubMed ID: 21054999)
21. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
[TBL] [Abstract][Full Text] [Related]
22. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
[TBL] [Abstract][Full Text] [Related]
23. [Expression and signification of pigment epithelium-derived factor in experimental choroidal neovascularization of rat].
Shi XH; He SZ; Zhao SH
Zhonghua Yan Ke Za Zhi; 2004 Jun; 40(6):404-8. PubMed ID: 15312607
[TBL] [Abstract][Full Text] [Related]
24. [Study on the experimental model of krypton laser-induced choroidal neovascularization in the rats].
Zhao SH; He SZ
Zhonghua Yan Ke Za Zhi; 2003 May; 39(5):298-302. PubMed ID: 12892608
[TBL] [Abstract][Full Text] [Related]
25. The role of estrogen and estrogen receptorbeta in choroidal neovascularization.
Tanemura M; Miyamoto N; Mandai M; Kamizuru H; Ooto S; Yasukawa T; Takahashi M; Honda Y
Mol Vis; 2004 Dec; 10():923-32. PubMed ID: 15616479
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
[TBL] [Abstract][Full Text] [Related]
27. Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor.
Csaky KG; Baffi JZ; Byrnes GA; Wolfe JD; Hilmer SC; Flippin J; Cousins SW
Exp Eye Res; 2004 Jun; 78(6):1107-16. PubMed ID: 15109917
[TBL] [Abstract][Full Text] [Related]
28. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
[TBL] [Abstract][Full Text] [Related]
29. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
Ishida K; Yoshimura N; Mandai M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334
[TBL] [Abstract][Full Text] [Related]
31. Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat.
Yanagi Y; Tamaki Y; Obata R; Muranaka K; Homma N; Matsuoka H; Mano H
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3495-9. PubMed ID: 12407161
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models.
Kim IT; Park HY; Choi JS; Joo CK
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3111-9. PubMed ID: 22491414
[TBL] [Abstract][Full Text] [Related]
33. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
[TBL] [Abstract][Full Text] [Related]
35. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
36. Impact of fenofibrate on choroidal neovascularization formation and VEGF-C plus VEGFR-3 in Brown Norway rats.
Zhao JF; Hua HR; Chen QB; Guan M; Yang JH; Xi XT; Li Y; Geng Y
Exp Eye Res; 2018 Sep; 174():152-160. PubMed ID: 29859143
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.
Recalde S; Zarranz-Ventura J; Fernández-Robredo P; García-Gómez PJ; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7090-7. PubMed ID: 21810978
[TBL] [Abstract][Full Text] [Related]
38. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
Lai CC; Wu WC; Chen SL; Xiao X; Tsai TC; Huan SJ; Chen TL; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2401-7. PubMed ID: 11527956
[TBL] [Abstract][Full Text] [Related]
39. Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovascularization in mice.
Hou HY; Wang YS; Xu JF; Wang BR
Exp Eye Res; 2008 Jun; 86(6):983-90. PubMed ID: 18472096
[TBL] [Abstract][Full Text] [Related]
40. VEGF is major stimulator in model of choroidal neovascularization.
Kwak N; Okamoto N; Wood JM; Campochiaro PA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3158-64. PubMed ID: 10967078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
